0
Amryt Pharma plc Banner Image

Amryt Pharma plc has reached its limit for free report views

Work for Amryt Pharma plc? Upgrade Your Profile and unlock all your annual reports.

Amryt Pharma plc

  • Ticker AMYT
    Exchange LSE More
  • Industry Drug Manufacturers - Other More
  • Sector Healthcare More
Amryt Pharma plc Logo Image
  • 51-200 Employees
  • Based in Dublin, Ireland
Amryt Pharma plc, a commercial-stage biopharmaceutical company, develops and commercializes novel therapeutics to treat patients suffering from serious and life-threatening rare diseases. The company offers Lomitapide for the treatment of homozygous familial hypercholesterolemia; and Metreleptin for the treatment of generalized and partial lipodystrophy. It also develops FILSUVEZ drug candidateMore, which is in Phase 3 EASE trial for the treatment of severe epidermolysis bullosa (EB), a rare and genetic skin disease; and AP103 that is in preclinical stage for the treatment of patients with recessive dystrophic EB, a subset of EB. The company sells its products in the Americas, Europe, and the Middle East. Amryt Pharma plc was founded in 2015 and is headquartered in Dublin, Ireland.
Amryt Pharma plc

Most Recent Annual Report

Amryt Pharma plc
MOST RECENT 2020 Annual Report

Report Locked. Amryt Pharma plc has reached its limit for free report views.

Older/Archived Annual Reports